课题基金 / 基金详情

INTEGRIN SIGNALING IN HCK-/-FGR-/-LYN-/-TUMOR CELLS

INTEGRIN SIGNALING IN HCK-/-FGR-/-LYN-/-TUMOR CELLS
HCK-/-FGR-/-LYN-/-肿瘤细胞中的整合素信号传导
批准号:
2520964
负责人:
FANYING MENG
金额:
$0.72万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
未结题
起止时间:
1998-09-11 至

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Integrins are involved in the regulation of multiple aspects of tumor cell biology such as proliferation, apoptosis, invasion, motility and tumor angiogenesis. However, the precise mechanism by which integrins trigger these biological processes in cancer is not well defined. One potential hypothesis is that these responses might relate to integrin- mediated signal transduction. Focal adhesion kinase (FAK) and Src-family kinases have been demonstrated to be involved in integrin-mediated signaling. To directly address the function of Src-family kinases, Hck, Fgr and Lyn in integrin signaling, we have generated triple mutant mice that are deficient for all three of these kinases. Primary macrophages derived from mutant mice show impaired tyrosine phosphorylation following integrin ligation indicating that three kinases are involved in integrin signal transduction. To further investigate the roles of Hck, Fgr and Lyn in integrin signaling in tumor cells, we will generate tumorigenic cell lines from the triple mutant mice, then characterize the integrin-related signaling events in these cells compared to wild type cells. The current proposal provides the best model system to study the functional importance of Src-family kinases in integrin signaling of tumor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金